# 119-hr-9682: Cure Hepatitis C Act of 2026

119-hr-9682, Cure Hepatitis C Act of 2026, is a 119th Congress bill sponsored by Rep. Miller-Meeks, Mariannette [R-IA-1] (R-IA); status introduced; PRIA reads it as touching household money (as of 2026-10-07).

- Canonical: https://policyrisk.com/legislation/119-hr-9682
- As of: 2026-10-07
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-9682
- Congress: 119
- Title: Cure Hepatitis C Act of 2026
- Status: introduced
- Introduced: 2026-07-14
- Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1] (R-IA)
- Cosponsors: 6
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-10-07

## Summary

**This bill would create a federal program to eliminate hepatitis C by expanding testing, treatment, and coordination nationwide.** It sets a national strategy, a public dashboard, and a subscription procurement model for treatments to boost access and monitoring. - People at risk and affected communities: Increases funding for screening, diagnosis, treatment, care coordination, and outreach aimed at priority populations and people with high incidence of hepatitis C. - People in correctional settings and those reentering the community: Authorizes distribution of treatments and testing to State and local correctional systems and the Bureau of Prisons and funds continuity-of-care measures after release. - Health providers, tribal programs, and health centers: Creates a subscription‑based purchase model, supports point-of-care diagnostic tests, funds provider training, and channels grants to community health centers, Indian health programs, opioid treatment programs, and behavioral health clinics. *Would appropriate $5.5 billion for fiscal year 2027 with funds available through 2033 and authorize up to $20 million for diagnostics, increasing federal spending.*

## Cosponsors (6)

- Rep. Auchincloss, Jake [D-MA-4] (D-MA), 2026-10-05T00:00:00.000Z
- Rep. Cleaver, Emanuel [D-MO-5] (D-MO), 2026-09-24T00:00:00.000Z
- Rep. DeGette, Diana [D-CO-1] (D-CO), 2026-07-14T00:00:00.000Z
- Rep. Johnson, Henry C. "Hank" [D-GA-4] (D-GA), 2026-07-14T00:00:00.000Z
- Rep. Bacon, Don [R-NE-2] (R-NE), 2026-07-14T00:00:00.000Z
- Rep. Gottheimer, Josh [D-NJ-5] (D-NJ), 2026-08-10T00:00:00.000Z

## Provisions PRIA read

- No Medicare cost-sharing for Hep C drugs: benefit, high. For plan years 2028 through 2032, this bill would eliminate the Medicare Part D deductible and all coinsurance or cost-sharing for direct-acting antiviral hepatitis C drugs. The Secretary could delay start from 2028 to 2029. The change would also remove deductible and cost-sharing for low-income su…
- Major funding for Hepatitis C program: benefit, high. This bill would appropriate $5.5 billion for FY2027, available through FY2033, to buy and distribute hepatitis C treatments under a subscription model. It would also appropriate $4.283 billion for FY2027, available through FY2033, for program awards and contracts. The Secretary would transfer $25 m…
- More hepatitis C testing and care: benefit, medium. This bill would fund training, technical assistance, and awards so more places can test for and treat hepatitis C. Grants and contracts would go to community health centers, States and local areas, correctional systems, Tribal health programs, opioid treatment programs, and behavioral health clinic…
- National Hepatitis C program and plan: benefit, medium. This bill would require HHS to start a Hepatitis C Elimination Program within 90 days. The Secretary would publish a national strategy and implementation plan within 180 days. The bill would create an advisory committee and an interagency working group to guide the program. HHS would also make a pu…
- Subscription prices counted for Medicaid: mixed, high. This bill would require that prices charged under the federal subscription program for hepatitis C drugs be counted when Medicaid calculates Best Price and Average Manufacturer Price. If enacted, that would lower Medicaid's net drug costs but could change how drug makers set prices and rebates acro…

## Related bills

- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-9237: Take Care of America’s Veterans Act
- 119-hr-2048: Metastatic Breast Cancer Access to Care Act
- 119-hr-1993: 25th Anniversary of 9/11 Commemorative Coin Act
- 119-hr-4669: FEMA Act of 2025
- 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

## Sources
- [119-hr-9682 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/9682)

## Related
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-9237: Take Care of America’s Veterans Act](https://policyrisk.com/legislation/119-hr-9237)
- [119-hr-2048: Metastatic Breast Cancer Access to Care Act](https://policyrisk.com/legislation/119-hr-2048)
- [119-hr-1993: 25th Anniversary of 9/11 Commemorative Coin Act](https://policyrisk.com/legislation/119-hr-1993)
- [119-hr-4669: FEMA Act of 2025](https://policyrisk.com/legislation/119-hr-4669)
- [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-9682 (as of 2026-10-07).